Stephen J. Meltzer MD
Professor of Medicine, Professor of Oncology, Johns Hopkins University School of Medicine
Join to View Full Profile
1800 Orleans StreetBaltimore, MD 21287
Phone+1 410-955-5000
Fax+1 410-955-5001
Dr. Meltzer is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Zucker School of Medicine at Hofstra/Northwell at Lenox Hill HospitalFellowship, Gastroenterology, 1984 - 1985
University of ColoradoFellowship, Gastroenterology, 1983 - 1984
University of Texas Medical Branch HospitalsResidency, Internal Medicine, 1980 - 1982
Tulane UniversityInternship, Internal Medicine, 1979 - 1980
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1979
Certifications & Licensure
CA State Medical License 1985 - Present
MD State Medical License 1988 - 2027
CO State Medical License 1982 - 1985
LA State Medical License 1979 - 1983
TX State Medical License 1980 - 1983
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
Clinical Trials
- EsophaCap for the Detection of Early Esophageal Carcinoma Start of enrollment: 2016 Jan 12
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 1 citationsA machine-learning informed circulating microbial DNA signature for early diagnosis of esophageal adenocarcinoma.Yuan Li, Caiming Xu, Hyun Park, Ashten N Omstead, Muhammad Anees
Gut Microbes. 2026-12-31 - 8 citationsDiscovery of Methylated DNA Biomarkers for Potential Nonendoscopic Detection of Barrett's Esophagus and Esophageal Adenocarcinoma.Andrew Kalra, Ke Ma, Yulan Cheng, Hua-Ling Tsai, Hao Wang
The American Journal of Gastroenterology. 2025-10-01 - Chromosome 20q gene signature associated with colorectal cancer progression.Jennifer Carter Jones, Apurva M Hegde, Yu-Jing Huang, Ganiraju Manyam, Vibhuti Srivastava
Oncology Reports. 2025-10-01
Journal Articles
- Inhibition of the miR-192/215–Rab11-FIP2 Axis Suppresses Human Gastric Cancer ProgressionStephen Meltzer, MD, Nature
Press Mentions
Castle Biosciences to Acquire PreviseMay 6th, 2025- American Journal of Gastroenterology Publishes Key Study Further Validating Esopredict® as a Prognostic Test for Barrett's EsophagusFebruary 12th, 2025
- HMN 2025: Researchers Develop Biomarker Algorithm to Non-Invasively Detect Barrett’s Esophagus and CancerJanuary 23rd, 2025
Grant Support
- Modeling Pathways of Early Growth Dysregulation at the GEJJOHNS HOPKINS UNIVERSITY2024–2029
- Academic-Industrial Partnership for Barrett's Esophagus Detection and Risk AssessmentJOHNS HOPKINS UNIVERSITY2024–2029
- Point-of-Care Diagnosis of Esophageal Cancer in LMICsJOHNS HOPKINS UNIVERSITY2023–2028
- Point-of-Care Diagnosis of Esophageal Cancer in LMICsJOHNS HOPKINS UNIVERSITY2023–2028
- The Temporal Epigenomic Program Of Barrett'S Neoplastic ProgressionNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
Other Languages
- French, German
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/stephen-meltzer
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
